Additionally, sufficient studies have suggested that SETD2, BAP1, mTOR, MUC16, HMCN1, KDM5C, ARID1A, and PTEN are intimately tied to prognosis and immune response in cancers (30–35). Here, ARID1A is linked to cancer.